Preparation of elaioplast and lipid compound preparation of nucleoside-phosphate compound
A technology of lipid complex and nucleoside phosphonic acid, which is applied in liposome delivery, medical preparations containing active ingredients, digestive system, etc. It can solve the problems of increased toxicity, large dosage, and low bioavailability , to improve the encapsulation rate, prolong the shelf life and improve the stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] The chloroform solution that will contain 164mg dioleoylphosphatidylcholine (DOPC) and 54mg cholesterol is added in eggplant-shaped bottle, water bath, rotary evaporation removes chloroform, after making it film-forming, continue vacuumizing 1 hour to remove residual chloroform, to Add 10ml of HEPES solution (pH=7) into the eggplant-shaped bottle, shake it, let it stand at room temperature for 2 hours, add hydrochloric acid solution to adjust the outer water phase to pH=4, add 10mg of tenofovir (PMPA), shake well, and keep warm for 2 hours. Forms a homogeneous opalescent liposome suspension.
[0030] The encapsulation efficiency of the nucleoside phosphonic acid compound in this example is 23%.
Embodiment 2
[0032] Add a chloroform solution containing 277mg distearoylphosphatidylcholine (DSPC), 52mg distearoylphosphatidylethanolamine (DSPE) and 108mg cholesterol to an eggplant-shaped bottle, and remove the chloroform by rotary evaporation in a water bath to form a film Afterwards, continue vacuuming for 1 hour to remove residual chloroform, add 10ml of HEPES solution (pH=7) to the eggplant-shaped bottle, shake, leave at room temperature for 2h, add hydrochloric acid solution to adjust the external water phase to pH=4, add 10mg of tenoxine Forovir, shake well and keep warm for 2 hours to form a uniform milky white liposome suspension.
[0033] In this example, the encapsulation efficiency of the nucleoside phosphonic acid compound is 35%.
Embodiment 3
[0035] A chloroform solution containing 652 mg of dipalmitoylphosphatidylcholine (DPPC), 337 mg of 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphatidylcholine (POPC) and 344 mg of cholesterol was added to an eggplant-shaped bottle, Water bath, rotary evaporation to remove chloroform, make it into a film, continue vacuuming for 1 hour to remove residual chloroform, add HEPES solution (pH=7) 10ml into eggplant-shaped bottle, shake, leave at room temperature for 2h, add hydrochloric acid solution to adjust Add 10 mg of adefovir (PMEA) to the aqueous phase until pH = 3, shake well, and keep warm for 2 hours to form a uniform milky white liposome suspension.
[0036] The encapsulation efficiency of nucleoside phosphonic acid compounds in this example was 54%.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com